Finally, according to PFI analysis, ORC6 high expression level acted as an unfavorable indicator for patients with 23 types of cancers (e.g., KIRP, LIHC and PRAD), and as a protective marker only in patients with GBM, OV, STAD, and THYM (Supplementary Fig. 7). Here, ORC6 is linked to glioblastoma.